How does metformin work
Pro Research Analysisby 
Searched over 200M research papers
Mechanisms of Action of Metformin
Metformin is a widely-used drug primarily prescribed for the treatment of type 2 diabetes. Despite its long history of use, the exact mechanisms by which it exerts its effects are complex and not fully understood. This article synthesizes current research to elucidate the multifaceted ways in which metformin works.
Inhibition of Hepatic Gluconeogenesis
One of the primary mechanisms by which metformin lowers blood glucose levels is through the inhibition of hepatic gluconeogenesis. This process involves the suppression of glucose production in the liver. Metformin achieves this by inhibiting mitochondrial complex I, which leads to a reduction in cellular respiration and energy production in liver cells 123. This inhibition results in decreased levels of cAMP and protein kinase A signaling, which are crucial for the action of glucagon, a hormone that promotes gluconeogenesis .
Activation of AMP-Activated Protein Kinase (AMPK)
Metformin also activates AMP-activated protein kinase (AMPK), a key cellular energy sensor that regulates lipid and glucose metabolism. Activation of AMPK by metformin leads to increased fatty acid oxidation, reduced lipogenesis, and enhanced glucose uptake in skeletal muscle 456. This activation is thought to be a result of the drug's effect on the AMP:ATP ratio, although the exact changes in this ratio are subtle and require sensitive detection methods .
AMPK-Independent Mechanisms
Recent studies have highlighted that metformin's effects are not solely dependent on AMPK activation. For instance, metformin has been shown to inhibit mitochondrial glycerophosphate dehydrogenase, which plays a role in the redox balance of the cell, thereby affecting gluconeogenesis independently of AMPK 139. Additionally, metformin's impact on the gut microbiota and intestinal barrier integrity also contributes to its glucose-lowering effects and improved insulin sensitivity .
Effects on Lipid Metabolism
Metformin has beneficial effects on lipid metabolism, which are partly mediated through AMPK activation. The drug reduces the expression of lipogenic enzymes and promotes fatty acid oxidation, thereby lowering circulating lipid levels and reducing fatty liver 46. These effects contribute to the overall improvement in metabolic health observed in patients taking metformin.
Potential Anti-Cancer Properties
Beyond its role in diabetes management, metformin is being investigated for its potential anti-cancer properties. The drug may influence tumorigenesis indirectly by lowering insulin levels and directly by inducing energetic stress in cancer cells . However, these effects are still under investigation and require further research to be fully understood.
Conclusion
Metformin exerts its glucose-lowering effects through a combination of mechanisms, including the inhibition of hepatic gluconeogenesis, activation of AMPK, and modulation of lipid metabolism. Additionally, AMPK-independent pathways and effects on the gut microbiota contribute to its overall efficacy. While much has been learned about how metformin works, ongoing research continues to uncover new insights into its complex mechanisms of action.
Sources and full results
Most relevant research papers on this topic